- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04986774
Rescue Intracranial Stenting in Acute Ischemic Stroke (RISIS)
September 3, 2021 updated by: Dr. Cuong Tran Chi, Can Tho Stroke International Services Hospital
In acute ischemic stroke caused by intracranial large vessel occlusion, rescue intracranial stenting has been recently a treatment option to achieve recanalization in patients with the failure of mechanical thrombectomy.
Nevertheless, there are few studies supporting this beneficial treatment in two cerebral circulations.
We aimed to analyse whether the use of rescue intracranial stenting would improve prognosis of patients at 3 months.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In Asia population, large intracranial arterial stenosis lesion accounts for more than 30% in common causes of ischemic stroke, compares with about 10% in Caucasian population every year.
Normally, in human brain, there are about 130 billion neurons but they are lost equivalent to their losses in approximately 3.6 years of normal aging in case of a large vessel ischemic stroke untreated each hour.
Consequently, after the success of 5 randomized controlled trials about the mechanical thrombectomy, which have been done from December 2010 to December 2014, all of guidelines recommended this technique as the first-line treatment in acute ischemic stroke.
However, the HERMES meta-analysis showed that revascularisation failure ratio 28.9% in patients older than 80 years.
Recently, in case of mechanical thrombectomy failure, many studies suggested the rescue intracranial stenting could be alternative urgently needed treatment to achieve permanent recanalization which is one of the most important factors impacting on clinical outcomes after acute ischemic stroke.
Hence, the aims of our study were to assess both the "non-poor" outcome at 3 months and the symptomatic intracerebral hemorrhage relating to procedure in patients receiving rescue intracranial stenting.
Study Type
Interventional
Enrollment (Actual)
85
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cần Thơ, Vietnam, 900000
- Can Tho SIS Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 105 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Evidence of intracranial large vessel occlusion.
- Absence of intracranial hemorrhage.
- Severe stenosis or reocclusion after mechanical thrombectomy.
Exclusion Criteria:
- Tandem lesion.
- Loss to follow-up after discharge.
- A severe or fatal combined illness before acute ischemic stroke.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Rescue Intracranial Stenting (RIS)
RIS in Acute Ischemic Stroke caused by intracranial large vessel occlusion
|
Rescue Intracranial Stenting in Acute Ischemic Stroke caused by intracranial large vessel occlusion
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The "non-poor" 3-month outcome rate.
Time Frame: 3 months
|
The "non-poor" 3-month outcome rate was accessed by modified Rankin Score (mRS), which comprised of included good (mRS 0 - ≤ 2) and fair (mRS 3).
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The symptomatic intracerebral hemorrhage rate.
Time Frame: 24 hours after rescue intracranial stenting.
|
The symptomatic intracerebral hemorrhage was defined as patient's intracerebral hemorrhage with postprocedural mRS ≥ 5 and there were no other evident causes for the increased mRS.
|
24 hours after rescue intracranial stenting.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Stracke CP, Fiehler J, Meyer L, Thomalla G, Krause LU, Lowens S, Rothaupt J, Kim BM, Heo JH, Yeo LLL, Andersson T, Kabbasch C, Dorn F, Chapot R, Hanning U. Emergency Intracranial Stenting in Acute Stroke: Predictors for Poor Outcome and for Complications. J Am Heart Assoc. 2020 Mar 3;9(5):e012795. doi: 10.1161/JAHA.119.012795. Epub 2020 Mar 3.
- Perez-Garcia C, Gomez-Escalonilla C, Rosati S, Lopez-Ibor L, Egido JA, Simal P, Moreu M. Use of intracranial stent as rescue therapy after mechanical thrombectomy failure-9-year experience in a comprehensive stroke centre. Neuroradiology. 2020 Nov;62(11):1475-1483. doi: 10.1007/s00234-020-02487-9. Epub 2020 Jun 30.
- Alexander MJ, Zauner A, Chaloupka JC, Baxter B, Callison RC, Gupta R, Song SS, Yu W; WEAVE Trial Sites and Interventionalists. WEAVE Trial: Final Results in 152 On-Label Patients. Stroke. 2019 Apr;50(4):889-894. doi: 10.1161/STROKEAHA.118.023996.
- Meyer L, Fiehler J, Thomalla G, Krause LU, Lowens S, Rothaupt J, Kim BM, Heo JH, Yeo L, Andersson T, Kabbasch C, Dorn F, Chapot R, Stracke CP, Hanning U. Intracranial Stenting After Failed Thrombectomy in Patients With Moderately Severe Stroke: A Multicenter Cohort Study. Front Neurol. 2020 Feb 14;11:97. doi: 10.3389/fneur.2020.00097. eCollection 2020.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2019
Primary Completion (Actual)
May 29, 2021
Study Completion (Actual)
August 29, 2021
Study Registration Dates
First Submitted
July 11, 2021
First Submitted That Met QC Criteria
July 31, 2021
First Posted (Actual)
August 3, 2021
Study Record Updates
Last Update Posted (Actual)
September 13, 2021
Last Update Submitted That Met QC Criteria
September 3, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Infarction
- Brain Infarction
- Intracranial Arterial Diseases
- Stroke
- Ischemic Stroke
- Brain Ischemia
- Ischemia
- Hemorrhage
- Cerebral Infarction
- Atherosclerosis
- Intracranial Hemorrhages
- Intracranial Arteriosclerosis
- Thrombotic Stroke
Other Study ID Numbers
- Can Tho SIS Hospital
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemic Stroke
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
University Hospital HeidelbergCompletedAcute Ischemic Stroke | Acute Ischemic Stroke AIS | Acute Ischemic Stroke PatientsGermany
-
University of CalgaryThe George Institute for Global Health, AustraliaRecruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Kessler FoundationNational Institute on Disability, Independent Living, and Rehabilitation...RecruitingStroke | Stroke Gait Rehabilitation | Stroke Ischemic | Balance Deficits | Stroke (CVA) or Transient Ischemic AttackUnited States
-
Nordsjaellands HospitalRigshospitalet, Denmark; Metropolitan University CollegeCompletedTransient Ischemic Attack | Stroke, Ischemic | Stroke HemorrhagicDenmark
-
University of MiamiNo longer availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; First Affiliated Hospital of Wenzhou Medical University and other collaboratorsRecruitingAcute Ischemic Stroke and Transient Ischemic AttacksChina
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
Jagiellonian UniversityCompletedStroke, Ischemic | Subacute StrokePoland
-
Hyogo Medical UniversityRecruitingAcute Ischemic Stroke | Endovascular Therapy | Acute Ischemic Stroke (AIS) Related to a Distal OcclusionJapan
Clinical Trials on Rescue intracranial stenting
-
Assiut UniversityNot yet recruitingIschemic Stroke | Thromboembolic Stroke
-
Xuanwu Hospital, BeijingUnknown
-
Can Tho Stroke International Services HospitalCompletedThrombosis | Stent Stenosis | Ischemic Stroke, AcuteVietnam
-
Dr. Cuong Tran ChiCompletedAcute Stroke | Ischemic Stroke, Acute | Vertebro Basilar IschemiaVietnam
-
Can Tho Stroke International Services HospitalCompletedAcute Stroke | Ischemic Stroke, AcuteVietnam
-
Can Tho Stroke International Services HospitalAcandis GmbHCompletedIschemic Stroke | Stent Stenosis | Intracranial AtherosclerosisVietnam
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Acandis GmbH; Phenox GmbHRecruitingStroke | Intracranial Atherosclerosis | Stroke, Acute IschemicSwitzerland
-
Ministry of Health, ChinaUnknownIntracranial AtherosclerosisChina
-
Acandis GmbHRecruiting
-
Yonsei UniversityCompletedAcute Ischemic Stroke | Intracranial Artery OcclusionKorea, Republic of